EUCTR2007-001216-23-AT进行中（未招募）不适用
Phase I Studie bei substituirten chronischen Opiatgebrauchern zur Aufhebung zusätzlicher Opioidwirkungen einer weiteren Opiatgebrauchern zur Aufhebung zusätlicher Opioidwirkungen einer weiteren Opiatdosis durch Gabe des Antagonisten Naloxon - Gobo - 2
Phoenux AG0 个研究点开始时间: 2007年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Persons being capable of understanding the objective of the study and the related measures
- •Persons participating in the trial on a totally voluntary bases
- •Male Patients
- •Age between 25 and 35 years
- •Opiate substitution patients, taking 600 mg per day of morphine as substitution treatment
- •Patients being opiate dependent for at least 3 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Not enabled to provide written informed consent before beginning any study related activities or placed under guardianship
- •Relevant co consummation of drugs or alcohol 2 weeks before start of the study
- •Acute corporal illness
- •Kidney or liver insufficiency
- •Anaemia (HB <13 g/dl)
- •Recurrent intake of medications other than substitution medication
- •Known hypersensitity to Morphine or Naloxone
- •Coloured or bleached hair /head, axial or pubic
- •Participating in any other studies involving investigational products
研究者
相似试验
招募中
2 期
The effects of minocycline on breathing during sleep in patients prescribed opioid drugs for chronic pain.Central sleep apnoeachronic painRespiratory - Sleep apnoeaAnaesthesiology - Pain managementACTRN12613000274774Repatriation General Hospital15
已完成
不适用
Prospective Observational Study on Opioid-induced Constipation in Patients with Cancer Pain in JapaOpioid-induced constipationJPRN-UMIN000025864SHIONOGI & Co., Ltd220
已完成
不适用
A study to evaluate the pharmacokinetic and pharmacodynamic equivalence of HSP-130 and United States-approved Neulasta (Registered Trademark) and European Union-approved Neulasta (Registered Trademark) administered as a single subcutaneous dose to healthy volunteers.The study will be conducted in healthy subjects. Neulasta is indicated for the treatment of cancer chemotherapy-induced neutropenia.Cancer - Any cancerACTRN12615001049561Hospira, Inc.150
已完成
1 期
Phase I exploratory clinical research on the use of High-Density Mesenchymal Stem Cell Scaffold-Free Autologous Constructs derived from adipose tissue for the donor site of mosaic plasty plugs for osteochondral regeneration therapyPatients with cartilage injury, osteochondritis dissecans, disengaged osteochondral bone fracture, or idiopathic osteonecrosis of the knee jointJPRN-UMIN000017944Kyushu University Hospital Department of Orthopedic Surgery5
招募中
不适用
Pharmacological study of chronomodulated capecitabine therapycancer, capecitabine, phase I, chronotherapy, biomarker, pharmacology, kanker, chronotherapie, fase INL-OMON24089etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital42